FIELD: medicine, narcology. SUBSTANCE: method involves administration to patient inhibitors of emetine hydrochloride type that suppress enzyme activity but does not induce vomiting. Onset, periodicity and daily dose of inhibitor intake by patient are measured depending on its clinical state in treatment period, i. e. in remission state, dipsomania or hang-over state. EFFECT: enhanced effectiveness of treatment. 3 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATMENT OF ALCOHOLISM | 2005 |
|
RU2323727C2 |
| EMETINE HYDROCHLORIDE GRANULATE, METHOD FOR ITS PREPARING AND MEDICINAL FORMULATION BASED ON THEREOF | 2006 |
|
RU2309731C1 |
| METHOD FOR TREATING THE CASES OF ALCOHOLISM | 0 |
|
SU1734752A1 |
| METHOD FOR TREATMENT OF AFFECTIVE DISORDERS SELECTED FROM MANIC-DEPRESSIVE PSYCHOSIS, CYCLOTHYMIA, SCHIZOAFFECTIVE PSYCHOSIS AND CAUSED BY EXCESSIVE ALCOHOL CONSUMPTION | 2021 |
|
RU2791700C2 |
| PREPARATION AND METHOD FOR PRODUCING THE PREPARATION FOR TREATING ALCOHOLISM AND DRUG ADDICTION | 2003 |
|
RU2252756C1 |
| METHOD OF ALCOHOLIC TOXICOSES TREATMENT | 2007 |
|
RU2350336C2 |
| AMINO ACIDS COMPOSITION FOR METHANOL POISONING PREVENTION AND TREATMENT | 2015 |
|
RU2627610C2 |
| ANTI-ALCOHOLIC BEVERAGE "API" | 2016 |
|
RU2625963C1 |
| METHOD FOR PREDICTING REMISSION DURATION IN ALCOHOL ADDICTED PATIENTS AT THE REMISSION DEVELOPMENT PERIOD | 2002 |
|
RU2238034C2 |
| METHOD OF TREATING PATIENTS ILL WITH ALCOHOLISM | 0 |
|
SU971337A1 |
